NDC 63629-5637

Trezix

Acetaminophen, Caffeine, Dihydrocodeine Bitartrate

Trezix is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Acetaminophen; Caffeine; Dihydrocodeine Bitartrate.

Product ID63629-5637_0f379aba-f28b-40b4-a2fc-d807829f2c70
NDC63629-5637
Product TypeHuman Prescription Drug
Proprietary NameTrezix
Generic NameAcetaminophen, Caffeine, Dihydrocodeine Bitartrate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2014-12-01
Marketing CategoryANDA / ANDA
Application NumberANDA204785
Labeler NameBryant Ranch Prepack
Substance NameACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
Active Ingredient Strength321 mg/1; mg/1; mg/1
Pharm ClassesFull Opioid Agonists [MoA],Opioid Agonist [EPC],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE]
DEA ScheduleCIII
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 63629-5637-1

30 CAPSULE in 1 BOTTLE (63629-5637-1)
Marketing Start Date2015-06-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63629-5637-4 [63629563704]

Trezix CAPSULE
Marketing CategoryANDA
Application NumberANDA204785
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-10-26
Inactivation Date2020-01-31

NDC 63629-5637-1 [63629563701]

Trezix CAPSULE
Marketing CategoryANDA
Application NumberANDA204785
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-06-04
Inactivation Date2020-01-31

NDC 63629-5637-2 [63629563702]

Trezix CAPSULE
Marketing CategoryANDA
Application NumberANDA204785
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-06-04
Inactivation Date2020-01-31

NDC 63629-5637-3 [63629563703]

Trezix CAPSULE
Marketing CategoryANDA
Application NumberANDA204785
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-07-13
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
ACETAMINOPHEN320.5 mg/1

OpenFDA Data

SPL SET ID:f90f87cb-77ad-45f4-8b59-09459090d988
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1190201
  • 1596108
  • Pharmacological Class

    • Full Opioid Agonists [MoA]
    • Opioid Agonist [EPC]
    • Central Nervous System Stimulant [EPC]
    • Methylxanthine [EPC]
    • Xanthines [CS]
    • Central Nervous System Stimulation [PE]

    NDC Crossover Matching brand name "Trezix" or generic name "Acetaminophen, Caffeine, Dihydrocodeine Bitartrate"

    NDCBrand NameGeneric Name
    63187-705Trezixacetaminophen, caffeine, dihydrocodeine bitartrate
    63629-5637Trezixacetaminophen, caffeine, dihydrocodeine bitartrate
    66992-340Trezixacetaminophen, caffeine, dihydrocodeine bitartrate
    66992-840Trezixacetaminophen, caffeine, dihydrocodeine bitartrate
    42195-840Acetaminophen, Caffeine, Dihydrocodeine BitartrateAcetaminophen, Caffeine, Dihydrocodeine Bitartrate

    Trademark Results [Trezix]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TREZIX
    TREZIX
    88326471 not registered Live/Pending
    Wraser Pharmaceuticals
    2019-03-05
    TREZIX
    TREZIX
    86660330 4889095 Live/Registered
    Wraser Pharmaceuticals
    2015-06-12
    TREZIX
    TREZIX
    77101832 3463260 Dead/Cancelled
    E5 Pharma, Inc.
    2007-02-07

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.